← Back to Search

Topical Analgesic

Lidocaine5% v Lidocaine3.6%,Menthol1.25% for Arthritis

N/A
Waitlist Available
Research Sponsored by J.A.R. Laboratories
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 10
Awards & highlights

Summary

A comparison of transdermal patches for efficacy, side effects and quality of life for patients with back pain and arthritis. The three arms in the trial were; prescription strength lidocaine 5%, over the counter lidocaine 3.6%, menthol 1.25% and placebo.

Eligible Conditions
  • Arthritis
  • Back Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day ten
This trial's timeline: 3 weeks for screening, Varies for treatment, and day ten for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Efficacy comparison of lidocaine 5% and lidocaine 3.6%, menthol 1.25% as measured by VAS numeric 0-10 pain scale
Secondary study objectives
Efficacy comparison of placebo and lidocaine 3.6%, menthol 1.25% as measured by VAS numeric 0-10 pain scale
Lidocaine
Lidocaine
+1 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Lidocaine5% v Lidocaine3.6%,Menthol1.25%Active Control2 Interventions
Daily patch Q12 followed by Q12 of no patch
Group II: Lidocaine 3.6%, menthol 1.25% v placeboPlacebo Group2 Interventions
Daily patch Q12 followed by Q12 of no patch

Find a Location

Who is running the clinical trial?

J.A.R. LaboratoriesLead Sponsor
~11 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top